Pfizer Inc (NYSE:PFE)

30.25
Data as of Apr 17
 +0.16 / +0.53%
Today’s Change
27.12
Today|||52-Week Range
32.96
-1.24%
Year-to-Date
Johnson & Johnson's 3 Major Strengths
Apr 17 / MotleyFool.com
The Four Types of Growth Stocks
Apr 11 / TheStreet.com
AbbVie Candidate in Pivotal Study - Analyst Blog
Apr 17 / Zacks.com
Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog
Apr 11 / Zacks.com
Pharmaceutical Stocks For Income, Value, And Growth Investors
Apr 17 / Benzinga
Why taxing Corporate America is hard to do
Apr 11 / Fortune
Dow 30 Stock Roundup: JNJ Beats, JPM Disappoints - Analyst Blog
Apr 17 / Zacks.com
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Apr 10 / MotleyFool.com
UK cancer charity and companies test new style of drug trial
Apr 16 / FT.com
Nektar Presents Pipeline Data - Analyst Blog
Apr 10 / Zacks.com
3 Biotech Opportunities Following This Selloff
Apr 16 / MotleyFool.com
3 Breast Cancer Drugs With Big Potential
Apr 10 / MotleyFool.com
The Biggest Biotech Wins of the Week
Apr 15 / MotleyFool.com
Next-Gen Breast Cancer Drugs Offer Patients Hope
Apr 09 / MotleyFool.com
Leaders Of The Pharmaceutical Pack
Apr 15 / StockTwits
Teva to Launch Generic Lovaza - Analyst Blog
Apr 09 / Zacks.com
Portola's Betrixaban Study Design Published - Analyst Blog
Apr 15 / Zacks.com
Why Goldman Sachs and Pfizer Held Back the Dow Tuesday
Apr 08 / MotleyFool.com
Tax Dodging Companies Cost You More Than $1,200 Each Year
Apr 15 / Benzinga
Update on Merck's MK-3475 - Analyst Blog
Apr 08 / Zacks.com
Does Pfizer Offer Good Value?
Apr 15 / MotleyFool.com
Encouraging Results from Pfizer's Palbociclib - Analyst Blog
Apr 08 / Zacks.com
3 Health Care Stocks Bucking the S&P Downtrend
Apr 15 / MotleyFool.com
Stock Market News for April 08, 2014 - Market News
Apr 08 / Zacks.com
Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?
Apr 14 / MotleyFool.com
Pfizer Blockbuster Zyvox Under Attack
Apr 08 / MotleyFool.com
Biotech Tweet of the Week: Love Being Private
Apr 14 / MotleyFool.com
5 Stocks Forging the Future of Breast Cancer Care
Apr 08 / MotleyFool.com
Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings
Apr 14 / Benzinga
Can J&J's Pharma Segment Deliver Meaningful Growth?
Apr 07 / MotleyFool.com
Johnson & Johnson Earnings: Will Tuesday Bring More Good News for J&J?
Apr 14 / MotleyFool.com
Pfizer's Plunge Leads the Dow's Triple-Digit Dive
Apr 07 / MotleyFool.com
Dow Today: Pfizer (PFE) Lower
Apr 14 / TheStreet.com
Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy?
Apr 07 / MotleyFool.com
3 Stocks Reiterated As A Buy: PFE, QCOM, T
Apr 14 / TheStreet.com
Pfizer Inc's Palbociclib Delivers the Goods
Apr 07 / MotleyFool.com
Hedge Funds Love These 3 Pharma Stocks
Apr 14 / StreetAuthority
Here's How Intel Corp.'s Executive Bonus Tweaks Help Shareholders Like You and Me
Apr 07 / MotleyFool.com
Acura Pharma Ends Agreement with Pfizer - Analyst Blog
Apr 11 / Zacks.com
Why investors should fear the return of the buyback
Apr 07 / Fortune
Top 40 Upcoming Earnings Releases
Apr 11 / Benzinga
Pfizer falls as treatment trial disappoints
Apr 07 / FT.com
FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?
Apr 11 / TheStreet.com
Intel Corporation Can't Move the Dow Today as Worries Grow Widespread
Apr 07 / MotleyFool.com
Can This Drug Be a Game Changer for Eli Lilly?
Apr 11 / MotleyFool.com
Dow Drops Despite Intel Upgrade; Pfizer, Visa Drag
Apr 07 / MotleyFool.com
3 Stocks Pushing The Drugs Industry Downward
Apr 11 / TheStreet.com
The AACR Annual Meeting May Move These 2 Stocks
Apr 07 / MotleyFool.com
Pfizer, Visa Weigh on the Dow Even as Banks Grab All the Attention
Apr 11 / MotleyFool.com
What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.?
Apr 04 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.